1. Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12–15 years. Issue 2 (26th August 2021) Authors: King, Hayley; Deshpande, Sanjay; Woodbridge, Tamsin; Hilliard, Tom; Standing, Jon; Lewis, Mary; Ward, Lesley; Finn, Adam; Roderick, Marion Journal: Archives of disease in childhood Issue: Volume 107:Issue 2(2022) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗